Ticker
VRCACompany Name
VERRICA PHARMACEUTICALS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Market Capitalization | Net Cash Flow - Issuance (Purchase) of Equity Shares | Net Cash Flow - Issuance (Repayment) of Debt Securities | Net Cash Flow - Dividends & Other Cash Distributions | Shareholder Yield |
---|---|---|---|---|---|
6/30/2025 | $ 64.42M | $ 39.64M | $ -8.8M | $ 0 | -47.87% |
3/31/2025 | $ 50.87M | $ 39.79M | $ -4.83M | $ 0 | -68.73% |
12/31/2024 | $ 59.49M | $ 39.79M | $ -924K | $ 0 | -65.33% |
9/30/2024 | $ 36.37M | $ 163K | $ -573K | $ 0 | 1.13% |
6/30/2024 | $ 133.13M | $ 153K | $ 43.75M | $ 0 | -32.98% |
3/31/2024 | $ 405.54M | $ 3K | $ 43.93M | $ 0 | -10.83% |
12/31/2023 | $ 223.55M | $ 30.31M | $ 44.08M | $ 0 | -33.28% |
9/30/2023 | $ 135.03M | $ 30.14M | $ 44.1M | $ 0 | -54.98% |
6/30/2023 | $ 222.52M | $ 57.21M | $ -43.75M | $ 0 | -6.05% |
3/31/2023 | $ 274.4M | $ 57.21M | $ -43.75M | $ 0 | -4.9% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
(-1 * CF - Equity -1 * CF - Dividends -1 * CF - Debt) / Market Cap
(=) Shareholder Yield
Shareholder Yield for VERRICA PHARMACEUTICALS INC is calculated as follows: (-1 * CF - Equity [ $ 211K ] -1 * CF - Dividends [ $ 0 ] -1 * CF - Debt [ $ 34.37M ]) / Market Cap [ $ 202.79M ]
(=) Shareholder Yield [ -17.05% ]
Minimum
Mar 31, 2025
Maximum
Sep 30, 2022
Average
Median
filtered constituents | 3.48K |
---|---|
min | -33.43% |
max | 34.45% |
average | 0.57% |
median | 1.07% |
std | 11.13% |